BSVL gets nod for trial of Ulinastatin for COVID-19
BSVL gets nod for trial of Ulinastatin for COVID-19
[ad_1]
Bharat Serums and Vaccines Ltd. (BSVL) has received approval from DCGI to conduct phase III clinical study on Ulinastatin for mild to moderate Acute Respiratory Distress Syndrome (ARDS) patients with COVID-19, the company said in a statement.
Clinical trial is expected to start at hospitals shortly. The mortality risk is higher when an individual with COVID-19 infection develops ARDS and…
View On WordPress
















